Sun Pharma Advanced Research Company Announces Board Transition as CEO Anil Raghavan Appointed Managing Director
Sun Pharma Advanced Research Company Ltd (SPARC) has announced significant changes concerning its senior management team. The company disclosed the retirement of Dr. Rajamannar Thennati from the Board of Directors, effective upon completion of his term at the upcoming 21st Annual General Meeting. Simultaneously, Mr. Anil Raghavan, who currently serves as Chief Executive Officer (CEO), has been appointed as Managing Director and CEO, effective August 11, 2026.Mr. Raghavan’s new role involves him being liable to retire by rotation at the 21st Annual General Meeting of the Company. The company confirmed that Mr. Anil Raghavan is not related to any other director of SPARC.
The transition marks a period of organizational update, with management detailing the profiles and reasons for change regarding both key personnel.
Personnel Changes Overview
Details regarding the appointment and retirement were formally documented, highlighting the backgrounds of the senior executives involved in the corporate structure transition.| Particulars | Mr. Anil Raghavan | Dr. Rajamannar Thennati |
|---|---|---|
| Reason for change | Appointment | Retirement |
| Date of appointment/cessation | August 11, 2026 | August 10, 2026 |
Profile Details of Senior Management Personnel
Mr. Anil Raghavan currently serves as the Chief Executive Officer and is responsible for developing and executing strategies to realize SPARC's vision as a Global Pharmaceutical Leader with a portfolio of innovative solutions. Operating from the Mumbai office, Mr. Raghavan also mentors AIRAMATRIX Private Limited, an early stage Machine Learning company focused on transforming drug development and clinical practice through high content image processing and deep learning.Prior to joining SPARC, Mr. Anil held consulting positions with major firms such as Arthur Andersen, KPMG, and Cambridge. His background spans varied segments including Media and Entertainment, Telecommunications, Health Care services, and Technology/Outsourcing. Mr. Raghavan is an Industrial Engineer who has a keen interest in the evolving science and technologies within pharmaceutical R&D and health care delivery.
Dr. Rajamannar Thennati's role was marked by retirement. The details provided confirmed his status as a director whose term concluded on August 10, 2026.
SPARC Stock Price Movement
Sun Pharma Advanced Research Company Limited shares today slipped by 1.78% to close at ₹259.42, shedding ₹4.72 from the previous day's close. The stock traded on a volume of 1.52 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.